(Q43814580)

27 November 2017

title

Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma (English)

1 reference

27 November 2017

1 reference

Xiaodong Guo

1

1 reference

27 November 2017

Lu Xiong

series ordinal

2

1 reference

27 November 2017

Lin Zou

series ordinal

3

1 reference

27 November 2017

Jingmin Zhao

series ordinal

4

1 reference

27 November 2017

publication date

15 February 2012

1 reference

Pathology Oncology Research

27 November 2017

published in

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

635-640

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-011-9488-2

27 November 2017

exact match

0 references

cites work

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic proteins in development and homeostasis of kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

The prognostic significance of BMP-6 signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic proteins in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Effect of transforming growth factor beta and bone morphogenetic proteins on rat hepatic stellate cell proliferation and trans-differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

BMP4 promotes prostate tumor growth in bone through osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9488-2

Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma.

21 January 2018

1 reference

12 December 2020

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

1 reference

12 December 2020

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

12 December 2020

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells

1 reference

12 December 2020

Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients

1 reference

12 December 2020

Genetic variation in bone morphogenetic protein and colon and rectal cancer

1 reference

12 December 2020

[Pitfalls in the classification of liver tumors]

1 reference

12 December 2020

mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma.

1 reference

12 December 2020

Clinical significance of BMP7 in human colorectal cancer

1 reference

12 December 2020

Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.

1 reference

12 December 2020

10.1007/S12253-011-9488-2

Identifiers

DOI

1 reference

27 November 2017

1 reference